MedPath

西安澜泰药业有限公司

Ownership
-
Established
2003-04-10
Employees
-
Market Cap
-
Website
http://www.xaltyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

24

NMPA:24

Drug Approvals

Sulfasalazine Suppositories

Product Name
柳氮磺吡啶栓
Approval Number
国药准字H20074194
Approval Date
Aug 18, 2023
NMPA

Sodium Houttuyfonate Suppositories

Product Name
鱼腥草素钠栓
Approval Number
国药准字H20063496
Approval Date
Aug 18, 2023
NMPA

Bifonazole Suppositories

Product Name
联苯苄唑栓
Approval Number
国药准字H20074151
Approval Date
Aug 18, 2023
NMPA

排石利胆片

Approval Number
国药准字Z20080602
Approval Date
Nov 23, 2022
NMPA

Miconazole Nitrate Ointment

Product Name
硝酸咪康唑乳膏
Approval Number
国药准字H20074179
Approval Date
Nov 23, 2022
NMPA

救尔心胶囊

Approval Number
国药准字Z20063918
Approval Date
Nov 23, 2022
NMPA

益视颗粒

Approval Number
国药准字Z20064412
Approval Date
Nov 23, 2022
NMPA

Bifonazole Cream

Product Name
联苯苄唑乳膏
Approval Number
国药准字H20074159
Approval Date
Nov 23, 2022
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H61023456
Approval Date
Jul 18, 2022
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H61023455
Approval Date
Jul 18, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.